Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.

Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S. Food and Drug Administration.

The End the Vaccine Carveout Act would expose vaccine makers to lawsuits that once drove companies out of the industry.